• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

    5/16/25 4:10:00 PM ET
    $HSIC
    $KKR
    Medical Specialities
    Health Care
    Investment Managers
    Finance
    Get the next $HSIC alert in real time by email

    Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein.

    In connection with the investment, William K. "Dan" Daniel, Executive Advisor to KKR and former Executive Vice President of Danaher Corporation, has officially joined Henry Schein's Board of Directors as an independent director. He joins Max Lin, Partner at KKR and leader of the firm's Health Care industry team in the Americas, who became a member of Henry Schein's Board of Directors on May 2, 2025.

    Max Lin leads the Health Care industry team within KKR, and since joining in 2005, he has overseen a number of investments in the areas of dental services and other health care providers, medical products and equipment, and health care software and information technology. Dan Daniel has over three decades of global leadership experience in industrial and health care sectors, including 14 years as Executive Vice President at Danaher, where he oversaw multiple segments and played a key role in advancing the company's culture and business system. In connection with each of their appointments, Mr. Lin was appointed to the Nominating and Governance Committee as Vice Chair; Mr. Daniel was appointed to the Compensation Committee; and each of Mr. Lin and Mr. Daniel was appointed to the Strategic Advisory Committee.

    "We are pleased to welcome Max and Dan to the Board as we embark on this exciting next chapter for Henry Schein," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "Their deep experience in health care, operations, and strategic growth will be invaluable as we continue executing on our BOLD+1 strategy and creating long-term value for our stakeholders."

    About Henry Schein, Inc.

    Henry Schein, Inc. (NASDAQ:HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

    Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

    A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.7 billion in 2024, and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.

    For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, LinkedIn.com/Company/HenrySchein, and @HenrySchein on X.

    About KKR

    KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR's insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR's investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE:KKR), please visit KKR's website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group's website at www.globalatlantic.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250516439220/en/

    Investors

    Ronald N. South

    Senior Vice President and Chief Financial Officer

    [email protected]

    (631) 843-5500



    Graham Stanley

    Vice President, Investor Relations and Strategic Financial Project Officer

    [email protected]

    (631) 843-5500



    Media

    Henry Schein

    Tim Vassilakos

    Executive Director, Global Corporate Communications

    [email protected]

    (516) 510-0926



    KKR

    Liidia Liuksila

    [email protected]

    Get the next $HSIC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HSIC
    $KKR

    CompanyDatePrice TargetRatingAnalyst
    Henry Schein Inc.
    $HSIC
    8/26/2025$83.00In-line → Outperform
    Evercore ISI
    Henry Schein Inc.
    $HSIC
    7/25/2025$75.00Buy → Hold
    Stifel
    KKR & Co. Inc.
    $KKR
    7/14/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    Henry Schein Inc.
    $HSIC
    7/14/2025$72.00Outperform → Neutral
    Robert W. Baird
    KKR & Co. Inc.
    $KKR
    7/9/2025$142.00Buy → Hold
    HSBC Securities
    KKR & Co. Inc.
    $KKR
    6/30/2025$150.00Overweight
    Piper Sandler
    KKR & Co. Inc.
    $KKR
    5/14/2025$150.00Equal-Weight → Overweight
    Morgan Stanley
    KKR & Co. Inc.
    $KKR
    4/15/2025$119.00Hold → Buy
    HSBC Securities
    More analyst ratings

    $HSIC
    $KKR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ecoplexus Announces Closing of $300 million Credit Facility from KKR to Accelerate Solar and Storage Development

    NEW YORK, Dec. 1, 2025 /PRNewswire/ -- Ecoplexus announced today that it has closed a $300 million credit facility from capital accounts advised by KKR, a leading global investment firm. The facility includes development capital and a letter of credit facility provided by Sumitomo Mitsui Banking Corporation (SMBC). It will support the advancement of over 13GW of solar and storage projects across the United States. "This financing marks an important milestone for our business and gives us the certainty and scale required to advance several GW of projects to start of constructio

    12/1/25 7:23:00 PM ET
    $KKR
    Investment Managers
    Finance

    Henry Schein Expands Partnership with vVARDIS

    Company to Serve As Exclusive Distributor of Curodont™ Repair Fluoride Plus Across All U.S. Dental Segments Henry Schein, Inc. (NASDAQ:HSIC) today announced the expansion of its agreement with vVARDIS, which grants the Company exclusive U.S. distribution rights for the drill-free Curodont™ Repair Fluoride Plus ("Curodont") product across all dental market segments, effective January 1, 2026. The strategic expansion broadens Henry Schein's previous exclusivity with the Swiss company, which was announced in 2024 for Dental Service Organizations (DSOs). Starting next year, the agreement will cover various areas of dental care, including general dentistry, orthodontics, and pediatric dentistr

    12/1/25 4:34:00 PM ET
    $HSIC
    Medical Specialities
    Health Care

    Henry Schein One Unveils Industry-first Natively Embedded Voice Workflow at 2025 Greater New York Dental Meeting

    Company announces smarter workflows for Dentrix and Dentrix Ascend platforms with a focus on clean claims Coming off the heels of its announcement with Amazon Web Services, Henry Schein One, the leading provider of global dental technology, today unveils natively embedded AI and automation workflows. This includes Voice Notes, which helps practices close revenue gaps through clean claims, and modernize more effectively. "Our goal isn't piecemeal AI and automation — it's natively embedded AI with a purpose," said Dr. Ryan Hungate, Chief Clinical and Strategy Officer at Henry Schein One. "We're seamlessly building it into every part of the practice. From the first phone call to the final pa

    11/25/25 6:30:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    $HSIC
    $KKR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Daniel William K bought $670,800 worth of shares (10,000 units at $67.08) (SEC Form 4)

    4 - HENRY SCHEIN INC (0001000228) (Issuer)

    8/11/25 4:26:33 PM ET
    $HSIC
    Medical Specialities
    Health Care

    Director Barakett Timothy R bought $4,127,319 worth of shares (35,000 units at $117.92) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    5/27/25 8:01:38 PM ET
    $KKR
    Investment Managers
    Finance

    Director Scully Robert W bought $1,503,733 worth of shares (13,250 units at $113.49) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    5/8/25 7:01:53 PM ET
    $KKR
    Investment Managers
    Finance

    $HSIC
    $KKR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman, CEO Bergman Stanley M gifted 140 units of Common Stock par value $0.01 per shre and gifted 500 shares, decreasing direct ownership by 0.20% to 319,877 units (SEC Form 4)

    4 - HENRY SCHEIN INC (0001000228) (Issuer)

    11/26/25 4:10:29 PM ET
    $HSIC
    Medical Specialities
    Health Care

    EVP & Chief Operating Officer Ettinger Michael S gifted 71 shares, decreasing direct ownership by 0.07% to 101,622 units (SEC Form 4)

    4 - HENRY SCHEIN INC (0001000228) (Issuer)

    11/21/25 4:14:47 PM ET
    $HSIC
    Medical Specialities
    Health Care

    Co-Executive Chairman Kravis Henry R gifted 350,000 shares (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    11/14/25 7:00:21 PM ET
    $KKR
    Investment Managers
    Finance

    $HSIC
    $KKR
    SEC Filings

    View All

    SEC Form 10-Q filed by KKR & Co. Inc.

    10-Q - KKR & Co. Inc. (0001404912) (Filer)

    11/7/25 4:45:56 PM ET
    $KKR
    Investment Managers
    Finance

    KKR & Co. Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - KKR & Co. Inc. (0001404912) (Filer)

    11/7/25 6:50:18 AM ET
    $KKR
    Investment Managers
    Finance

    SEC Form 10-Q filed by Henry Schein Inc.

    10-Q - HENRY SCHEIN INC (0001000228) (Filer)

    11/4/25 2:33:28 PM ET
    $HSIC
    Medical Specialities
    Health Care

    $HSIC
    $KKR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Henry Schein upgraded by Evercore ISI with a new price target

    Evercore ISI upgraded Henry Schein from In-line to Outperform and set a new price target of $83.00

    8/26/25 8:13:41 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Henry Schein downgraded by Stifel with a new price target

    Stifel downgraded Henry Schein from Buy to Hold and set a new price target of $75.00

    7/25/25 8:58:32 AM ET
    $HSIC
    Medical Specialities
    Health Care

    KKR downgraded by Citizens JMP

    Citizens JMP downgraded KKR from Mkt Outperform to Mkt Perform

    7/14/25 8:40:54 AM ET
    $KKR
    Investment Managers
    Finance

    $HSIC
    $KKR
    Leadership Updates

    Live Leadership Updates

    View All

    Peak Re Welcomes KKR and Quadrantis Capital as Minority Investors

    Peak Reinsurance Company Limited ("Peak Re" or the "Company") and KKR, a leading global investment firm, today announced that funds managed by KKR and Quadrantis Capital have entered into definitive agreements to acquire minority stakes in Peak Re via Peak Reinsurance Holdings Limited. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251020924186/en/ Upon completion, KKR and Quadrantis Capital are expected to hold approximately 11.27% and approximately 1.80% of Peak Re's issued share capital, respectively, with the remaining approximately 86.71% continuing to be held by the majority shareholder, Fosun International Limited. Pruden

    10/20/25 9:05:00 PM ET
    $KKR
    Investment Managers
    Finance

    KKR Appoints Craig Arnold to Board

    KKR & Co. Inc. (NYSE:KKR) today announced that Craig Arnold has been appointed to the Board of Directors effective September 23, 2025. His appointment will bring the number of independent directors to eleven out of a total of fifteen Board seats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250924641078/en/Craig Arnold Mr. Arnold is the former Chairman and Chief Executive Officer of Eaton Corporation, a global intelligent power management company. KKR's other Board members are: Henry Kravis (Co-Founder and Co-Executive Chairman of KKR), George Roberts (Co-Founder and Co-Executive Chairman of KKR), Joseph Bae (Co-Executive Of

    9/24/25 4:30:00 PM ET
    $KKR
    Investment Managers
    Finance

    KKR Appoints Former AWS CEO Adam Selipsky as Senior Technology and AI Strategy Advisor

    Mr. Selipsky to advise on KKR's $179B Real Assets platform as digital infrastructure retools for the AI era KKR, a leading global investment firm, today announced the appointment of Adam Selipsky, former Chief Executive Officer of Amazon Web Services (AWS), as a Senior Technology and AI Strategy Advisor to the firm. Mr. Selipsky, one of the most recognized leaders in cloud and enterprise technology, will help guide KKR's global digital infrastructure platform as the firm accelerates investments in the next generation of AI, data centers and energy. Mr. Selipsky has more than 20 years of executive leadership experience in scaling mission-critical internet infrastructure. At AWS, he helpe

    9/3/25 7:00:00 AM ET
    $KKR
    Investment Managers
    Finance

    $HSIC
    $KKR
    Financials

    Live finance-specific insights

    View All

    KKR to Launch Tender Offer for Forum Engineering

    Marks KKR's First Global Impact Investment in Japan KKR, a leading global investment firm, and Forum Engineering Inc. ("Forum Engineering"; TSE stock code 7088), announced today that KKR will launch a tender offer for the common shares and share options of Forum Engineering (the "Tender Offer") through KJ003 Co., Ltd. (the "Offeror"), an entity owned by investment funds managed by KKR. Forum Engineering's Board of Directors has resolved to support the Tender Offer and recommend that shareholders tender their shares.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251109696853/en/ The Tender Offer will commence on November 11,

    11/10/25 1:30:00 AM ET
    $KKR
    Investment Managers
    Finance

    KKR & Co. Inc. Reports Third Quarter 2025 Results

    KKR & Co. Inc. (NYSE:KKR) today reported its third quarter 2025 results, which have been posted to the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251107557033/en/ A conference call to discuss KKR's financial results will be held today, Friday, November 7, 2025 at 9:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Center

    11/7/25 6:50:00 AM ET
    $KKR
    Investment Managers
    Finance

    FS KKR Capital Corp. Announces Third Quarter 2025 Results

    PHILADELPHIA and NEW YORK, Nov. 5, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter ended September 30, 2025, and that its board of directors previously, on October 8, 2025, declared a fourth quarter 2025 distribution of $0.70 per share. Financial and Operating Highlights for the Quarter Ended September 30, 2025(1) Net investment income of $0.57 per share, compared to $0.62 per share for the quarter ended June 30, 2025Adjusted net investment income(2) of $0.57 per share, compared to $0.60

    11/5/25 4:15:00 PM ET
    $FSK
    $KKR
    Investment Managers
    Finance

    $HSIC
    $KKR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Henry Schein Inc.

    SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)

    11/13/24 3:30:01 PM ET
    $HSIC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by KKR & Co. Inc.

    SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)

    11/12/24 3:50:17 PM ET
    $KKR
    Investment Managers
    Finance

    SEC Form SC 13G filed by Henry Schein Inc.

    SC 13G - HENRY SCHEIN INC (0001000228) (Subject)

    11/12/24 9:32:27 AM ET
    $HSIC
    Medical Specialities
    Health Care